Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (16)

2024

  1. Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples

    International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722

  2. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

2023

  1. A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

    Biomedicine and Pharmacotherapy, Vol. 159

  2. Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis

    STAR Protocols, Vol. 4, Núm. 4

  3. Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships

    European Journal of Medical Genetics, Vol. 65, Núm. 11

  3. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

  4. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

    British Journal of Cancer

  5. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2021

  1. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

2020

  1. Small-molecule inhibitors (Smis) as an effective therapeutic strategy for endometrial cancer

    Cancers, Vol. 12, Núm. 10, pp. 1-26

2019

  1. Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85

2017

  1. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium

    Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458

  2. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164

  3. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026